leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2019 |
Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.030 |
None |
0.667 |
3 |
|
2016 |
2019 |
Malignant melanoma of iris
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
10
|
1
|
0.410 |
None |
1.000 |
3 |
|
2013 |
2018 |
RETINOSCHISIS 1, X-LINKED, JUVENILE
|
disease |
|
Disease or Syndrome
|
33
|
59
|
0.030 |
None |
0.667 |
3 |
|
2012 |
2019 |
Bradykinesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
133
|
16
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
mucosal melanoma
|
disease |
|
Neoplastic Process
|
24
|
1
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Dementia
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
816
|
176
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
Thrombocythemia, Essential
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
220
|
37
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2019 |
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Iron Overload
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
241
|
53
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Childhood Acute Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
215
|
6
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2019 |
Malignant melanoma of choroid
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
27
|
5
|
0.400 |
None |
1.000 |
2 |
|
2013 |
2013 |
Parkinsonian Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
373
|
95
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Nonorganic psychosis
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
376
|
98
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Juvenile Myelomonocytic Leukemia
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
179
|
70
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2013 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Muscle Rigidity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
320
|
25
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.310 |
None |
1.000 |
2 |
|
2018 |
2019 |
Trisomy 12
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
76
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Monosomy
|
group |
Pathological Conditions, Signs and Symptoms
|
Congenital Abnormality
|
214
|
11
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2019 |
Refractory anemia with excess blasts I
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2012 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2016 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
PARKINSON DISEASE, LATE-ONSET
|
disease |
|
Disease or Syndrome
|
247
|
76
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |